3.0.0 7971 2023-01-11T13:45:29Z 2023-01-11T13:45:29Z House HR 2020-08-07 116 [Congressional Record Volume 166, Number 141 (Friday, August 7, 2020)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. KRISHNAMOORTHI:H.R. 7971.Congress has the power to enact this legislation pursuantto the following:clause 3 of Section 8 of Article I (Commerce Clause); andclause 18 of section 8 of Article I (Necessary and ProperClause).[Page H4226]]]> hsif00 Energy and Commerce Committee House Standing Referred to 2020-08-07T14:01:05Z 2020-08-07 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2020-08-07 Introduced in House IntroReferral Intro-H 9 Library of Congress 2020-08-07 Introduced in House IntroReferral 1000 9 Library of Congress K000391 Rep. Krishnamoorthi, Raja [D-IL-8] Raja Krishnamoorthi D IL 8 N C001078 Rep. Connolly, Gerald E. [D-VA-11] Gerald Connolly D VA E. 11 2020-08-07 True T000481 Rep. Tlaib, Rashida [D-MI-13] Rashida Tlaib D MI 13 2020-08-07 True P000617 Rep. Pressley, Ayanna [D-MA-7] Ayanna Pressley D MA 7 2020-08-07 True P000618 Rep. Porter, Katie [D-CA-45] Katie Porter D CA 45 2020-08-07 True K000389 Rep. Khanna, Ro [D-CA-17] Ro Khanna D CA 17 2020-08-07 True D000623 Rep. DeSaulnier, Mark [D-CA-11] Mark DeSaulnier D CA 11 2020-08-07 True M001196 Rep. Moulton, Seth [D-MA-6] Seth Moulton D MA 6 2020-09-04 False Health Advisory bodies Cardiovascular and respiratory health Department of Health and Human Services Drug safety, medical device, and laboratory regulation Emergency medical services and trauma care Food and Drug Administration (FDA) Government information and archives Immunology and vaccination Infectious and parasitic diseases Licensing and registrations Medical research Public participation and lobbying Health 00 2020-08-07 Introduced in House 2021-09-13T14:15:16Z Expeditious Vaccine Advice with Legitimate, Unbiased, Apolitical, and Technical Expertise Act or the EVALUATE Act

This bill requires the Food and Drug Administration, before licensing or authorizing any COVID-19 (i.e., coronavirus disease 2019) vaccine, to receive advisory committee recommendations concerning the vaccine's safety and effectiveness.

]]> EVALUATE Act Display Title EVALUATE Act Short Title(s) as Introduced EVALUATE Act Introduced in House IH Short Title(s) as Introduced Expeditious Vaccine Advice with Legitimate, Unbiased, Apolitical, and Technical Expertise Act Introduced in House IH Official Title as Introduced To direct the Food and Drug Administration to solicit and consider the recommendations of the Vaccines and Related Biological Products Advisory Committee before taking certain actions with respect to COVID-19 vaccines, and for other purposes. Introduced in House IH Introduced in House 2020-08-07T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116hr7971ih/xml/BILLS-116hr7971ih.xml 2020-08-07 Referred to the House Committee on Energy and Commerce. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.